# Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

> **NCT06526065** · — · RECRUITING · sponsor: **University Medical Center Goettingen** · enrollment: 500 (estimated)

## Conditions studied

- DLBCL - Diffuse Large B Cell Lymphoma

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT06526065
- **Lead sponsor:** University Medical Center Goettingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-20
- **Primary completion:** 2026-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06526065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06526065, "Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06526065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*